
The Cancer Researcher Podcast
by The European Association for Cancer Research (EACR)
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1,001 - 10,000 - Monthly Reach
Unique listeners across all episodes (30 days)
5,001 - 25,000 - Active Followers
Loyal subscribers who consistently listen
501 - 5,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Patients Shaping Cancer Research
Apr 13, 2026
34m 07s
From Bedside to Bench: Lessons from three award-winning scientists
Mar 13, 2026
37m 03s
A lifelong quest to understand cancer and cellular plasticity: Prof Xin Lu’s research journey following P53
Feb 13, 2026
23m 45s
Using AI to bridge chemistry, proteomics and precision medicine: Prof Bernhard Küster’s research journey
Jan 16, 2026
16m 42s
Research Focus: How Dietary Fats Shape Immune Defenses Against Cancer
Dec 5, 2025
22m 49s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 4/13/26 | Patients Shaping Cancer Research | What does it take to bridge the gap between researchers and patients? This episode features a panel of scientists, researcher-oncologists, and patient advocates from several European countries (France, Belgium, Switzerland, and Slovenia) as well as Canada and the United States. They discuss how collaboration between patients and researchers can be promoted in order to strengthen research outcomes. Our guests address the importance of sharing medical data, biomarkers, and collective learning, while also considering related issues like the right to be forgotten or diagnosis- related discrimination, before focusing on the development of meaningful research advocate partnerships. Different existing models of incorporating patient opinions are discussed alongside some practical advice and calls for action for both patients and researchers to help move these efforts forward. This episode has been adapted, with permission from the panellists, from the open forum discussion at the EACR-OECI Conference on Patient Involvement in Cancer Research, a virtual event held on 28 October 2025. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 34m 07s | ||||||
| 3/13/26 | From Bedside to Bench: Lessons from three award-winning scientists | What happens when clinical care directly informs scientific discovery? This episode sees EACR award winners Charlie Swanton, Ayelet Erez and Daniel Kirschenbaum reflect on what drew them to pursuing cancer research alongside patient care, how bedside experiences guide lab investigations, and what it takes to turn a promising finding into real clinical progress. We also touch on recent breakthroughs in their work, and the biggest changes they’ve witnessed in the field. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 37m 03s | ||||||
| 2/13/26 | A lifelong quest to understand cancer and cellular plasticity: Prof Xin Lu’s research journey following P53 | Professor Xin Lu, Director of the Ludwig Institute for Cancer Research, Oxford Branch, and keynote speaker at EACR 2026, talks about her scientific journey shaped by the early, influential studies of P53 and its role as a central tumour suppressor. Tracing her journey from early training in China to landmark work in the UK, the conversation explores how fundamental questions about DNA damage, cell death, and oncogene stress led to the discovery of the ASPP family of P53 regulators. The discussion further expands into the concept of cellular plasticity as a driving force in cancer initiation, progression, and therapy resistance, with insights into how tumour suppressors, infection, and environmental stress shape cellular identity. Together, these reflections highlight how decades of curiosity-driven research have helped define modern cancer biology. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 23m 45s | ||||||
| 1/16/26 | Using AI to bridge chemistry, proteomics and precision medicine: Prof Bernhard Küster’s research journey | Professor Bernhard Küster, keynote speaker at EACR 2026, talks about his scientific journey from chemistry to chemical proteomics and precision medicine. He reflects on how an interdisciplinary mindset - combining chemistry, biology, and computational science - has shaped his approach to understanding how drugs act on proteins and how this knowledge can inform personalised cancer treatments. He also shares practical advice for early-career researchers on how to embrace interdisciplinarity in their work. Bernhard discusses his team’s pioneering work developing technologies such as Prosit, Decrypt-E and Decrypt-M, and highlights how artificial intelligence is accelerating discoveries in proteomics. He also underscores the vital role of the clinical community in providing well-annotated tumour samples - an essential foundation for meaningful AI-driven cancer research. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 16m 42s | ||||||
| 12/5/25 | Research Focus: How Dietary Fats Shape Immune Defenses Against Cancer | What you eat – specifically the type of fat – might matter for how well your immune system can fight cancer under conditions of obesity. Dr. Hannah Prendeville and Dr. Britta Kunkemoeller, two key researchers behind this work, will discuss the key mechanisms they uncovered that involve weakened immune systems’ “killer” cells. 🔗 Read more about the publication: https://magazine.eacr.org/highlights-in-cancer-research-december-2025/6 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 22m 49s | ||||||
| 11/7/25 | Behind the Scenes at the EACR Congress | Conferences don’t just happen – people make them. In this episode, Johanna Joyce, Joana Paredes and Mariangela Russo take you behind the scenes of the Annual Congress of the European Association for Cancer Research, from shaping sessions and selecting speakers to fostering early career opportunities and spotting emerging science. Hear their reflections on EACR 2025 in Lisbon and get an insider glimpse of the themes and initiatives planned for EACR 2026 in Budapest. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 24m 59s | ||||||
| 10/10/25 | Unlocking Cancer's Neural Code: A Deep (Molecular) Dive into Cancer Neuroscience with Trace-n-Seq | In this episode, we take a quick dive into the rapidly evolving field of cancer neuroscience. Joining us are Dr. Andreas Trumpp and Dr. Vera Thiel from DKFZ and HI-STEM, who introduce Trace-n-Seq, a groundbreaking technology that enables the molecular characterization of neurons within tumours at single-cell resolution. We discuss the application of this cutting-edge innovation in pancreatic cancer, from the insights it offers into neuron–cancer–microenvironment interactions, to the powerful clinical implications. This episode focuses on the following publication in Nature (10.1038/s41586-025-08735-3), highlighted in a recent edition of the EACR’s Highlights in Cancer Research. 🔗 Read more about the publication: https://magazine.eacr.org/highlights-in-cancer-research-july-2025/9/ 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 17m 57s | ||||||
| 9/12/25 | Bugging Cancer: Engineering Salmonella for Cancer Therapy | Two of the biggest challenges for the treatment of most solid cancers are drug toxicity, particularly systemic toxicity, and drug permeation in the tumoral tissue. These obstacles may be mitigated through the development of intracellular delivery systems designed to selectively deliver drugs to the tumour. In this episode, we discuss with Dr. Vishnu Raman, CSO and co-founder at Ernst Pharmaceuticals, the benefits and challenges of using genetically engineered Salmonella strains as a vector for the transport of therapeutic proteins into malignant cells. The focus will be on his recent publication in Molecular Therapy (10.1016/j.ymthe.2024.12.038), highlighted in a recent edition of the EACR’s Highlights in Cancer Research. 🔗 Read more about the publication: https://magazine.eacr.org/highlights-in-cancer-research-march-2025/3/ 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 29m 05s | ||||||
| 6/6/25 | Research focus: novel approach to advance treatment of KRAS-driven non-small cell lung cancer based on ERK5 and FAK inhibition | We speak with Dr. Georgia Konstantinidou and Dr. Chiara Pozzato from University of Bern about their recent pre-clinical research investigating a new potential treatment approach for KRAS driven cancers. The conversation explores the role of FAK signalling in KRAS driven NSCLC and potential approaches to bypass drug resistance against FAK inhibitors from the molecular mechanisms involved to the impact of their study for the wider cancer research community. This study has been published in EMBO Molecular Medicine and was included in the EACR's Highlights in Cancer Research, a summary of the most interesting and impactful recent papers in cancer research. 🔗 Read more about the publication: https://magazine.eacr.org/highlights-in-cancer-research-december-2024/7/ 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 20m 48s | ||||||
| 5/9/25 | Curiosity, optimism and collaboration: research insights from three award winning scientists | In this insightful and honest conversation, award winners Karin de Visser, Ido Amit and Marta Kovatcheva talk about their research, career journeys, and excitement for the future of cancer research. From curiosity and scientific breakthroughs to diversity and balancing life in the lab, they reflect on what it really means to be a researcher today. This episode explores the evolution of the cancer field and why optimism is more important than ever in science. The episode ends with a look ahead to the EACR 2025 Congress in Lisbon, where they’ll join fellow scientists from across the globe to share research and shape the future of cancer science. Karin de Visser is winner of the Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award Ido Amit is winner of the Pezcoller Foundation-EACR Translational Cancer Research Award Marta Kovatcheva is winner of the EACR-Mark Foundation-Pezcoller Foundation Rising Star Award 🔗 Find out more about the EACR Congress at eacr.org/congress 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 39m 05s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/11/25 | Charlie Swanton on perseverance, scientific change and asking questions | In this episode of The Cancer Researcher Podcast we interview Professor Charlie Swanton, Deputy Clinical Director of the Francis Crick Institute and Chief Clinician at Cancer Research UK on his research interests, the evolution of the field and how he turned round his failing PhD. Charlie also shares with us what he’s looking forward to at the EACR Congress ahead of his Keynote Lecture and gives some excellent advice to early-career researchers on how to break away from the shyness that could hold some back from asking questions and networking at conferences. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast. 🔗 Find out more about the EACR Congress at eacr.org/congress | 24m 08s | ||||||
| 3/14/25 | Research focus: beating cancer at its own game - the effects of oncogenic signaling hyperactivation on cancer progression | In this episode of the Cancer Researcher Podcast we interview Matheus Diaz about his research in Rene Bernards' lab on a ‘paradoxical’ approach to cancer treatment involving the activation of oncogenic signaling. The conversation explores how this method potentially kills cancer cells and addresses drug resistance, based on Diaz's fascinating recent publication in Cancer Discovery. 🔗 Read more about the publication: https://magazine.eacr.org/highlights-in-cancer-research-december-2024/10/ 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast | 25m 42s | ||||||
| 2/14/25 | Insights from a Keynote Speaker | In this episode of The Cancer Researcher Podcast we welcome back Professor Carlos Caldas, Clinician Scientist and Professor of Cancer Medicine at the University of Cambridge. As a keynote speaker at the upcoming EACR Congress, he shares insights into his breast cancer research, the evolution of cancer science, and the power of patient-derived xenograft models. We also discuss the Congress programme, networking tips for early-career researchers, and why Lisbon is the perfect host city. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast. 🔗 Find out more about the EACR Congress at eacr.org/congress | 20m 15s | ||||||
| 12/16/24 | Collaborating Across Borders | Cross-border collaboration is crucial in cancer research because it fosters knowledge-sharing, accelerates innovation, and maximises the impact of research by leveraging diverse expertise and resources. However, it also comes with many challenges. In this episode of The Cancer Researcher Podcast we're joined by four renowned experts — the Director of EMBO, the Director of Research and Partnerships at Cancer Research UK, the Past President of the European Academy of Cancer Sciences, and the Past President of the EACR. The guests discuss the complexities and benefits of cross-border collaboration in cancer research, emphasising the need for careful planning and understanding diverse funding models. They also explore the balance between discovery science and translational research, the importance of investigator-initiated and pragmatic clinical trials, and how such approaches can drive innovation and reduce healthcare costs. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast. 🔗 Celis, J. and Ringborg, U. (2024), From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021-lessons learned and implications. Mol Oncol, 18: 785-792. https://doi.org/10.1002/1878-0261.13632 | 47m 25s | ||||||
| 11/22/24 | Research focus: the impact of chronic stress on tumour progression | A cancer diagnosis is understandably stressful for a patient. But how does chronic stress influence cancer progression and metastasis? In this episode, Dr. Xue-Yan He discusses her recent research on the impact of stress on the tumour microenvironment, with a focus on the altered balance between neutrophils and lymphocytes and its role in promoting tumour spread. This study, published in Cancer Cell (Volume 42, Pages 474–486), was selected for the EACR Highlights in Cancer Research, showcasing its significance to the field. 🔗 Read the Cancer Cell article: https://doi.org/10.1016/j.ccell.2024.01.013 🔗 Explore the EACR Highlights: https://magazine.eacr.org/highlights-in-cancer-research-june-2024/3/ 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast. Tune in for an in-depth discussion on the interplay between stress and cancer biology, and its implications for understanding tumour progression. | 23m 49s | ||||||
| 10/25/24 | Research focus: a novel pan-lysyl oxidase inhibitor for improving the treatment of pancreatic cancer | Dr. Jessica Chitty and Dr. Thomas Cox generated and validated a novel selective and irreversible pan-lysyl oxidase inhibitor: PXS-5505. Their experiments in a series of pre-clinical models show that by acting on the tumour microenvironment, this small molecule drug has the ability to significantly enhance chemotherapy efficacy. Listen to this episode to find out direct from the authors about the effects that PXS-5505 in combination with gemcetabine has on tumour morphology, behaviour and subject survival in pancreatic cancer. This study has been published in Nature Cancer and was included in the EACR's Highlights in Cancer Research, a summary of the most interesting and impactful recent papers in cancer research. Access transcripts for all our episodes at magazine.eacr.org/podcast. | 21m 08s | ||||||
| 9/27/24 | Scientific management as a career | Have you ever wondered what it would be like to pursue a career in scientific management? What would a regular workday look like? What skills are valued in this sector and what are the opportunities for career progression? Tune into this episode of The Cancer Researcher Podcast for an insightful conversation with our three expert guests who each work in scientific management in different positions and sectors. Our guests in this episode: Lynn Turner, Director of Research at Worldwide Cancer Research Olivia Tort, International Project Manager at IRB Barcelona Javier Carmona, Head of Scientific Strategy and Translational Programs at Vall d'Hebron Institute of Oncology Access transcripts for all our episodes at magazine.eacr.org/podcast. | 29m 40s | ||||||
| 9/16/24 | Trailer | Welcome to The Cancer Researcher Podcast, from the European Association for Cancer Research. | 2m 30s | ||||||
| 7/19/24 | Editing as a Scientific Career | Does becoming an editor mean you are leaving research? Can you ever go back to academia? And why should you "follow the cookies"? Join us as we chat with seasoned professionals who have transitioned from the lab bench to the editorial desks at Molecular Oncology, Nature Reviews and Cell. They share their personal journeys, highlight the skills necessary for this unique career path, and offer advice for researchers considering a shift into scientific publishing. Access transcripts for all our episodes at magazine.eacr.org/podcast. | 36m 41s | ||||||
| 6/24/24 | Demystifying scientific publishing | In this episode we're joined by editors from Cell, Nature Reviews and Molecular Oncology to discuss the process of scientific publishing: from the steps involved, including the peer review stage, to choosing the best home for your research; from preprints to peer-reviewed journals; from APCs and how to get a discount to the importance of engaging in an open conversation about your research with editors even prior to your paper submission. Access transcripts for all our episodes at magazine.eacr.org/podcast. | 42m 31s | ||||||
| 5/10/24 | Interview Tips from the Experts | In this episode you'll learn top tips from experts in both academia and industry to help you master your next interview. Discover strategies for overcoming nerves, handling unexpected questions, and making a lasting impression, whether in-person or via Zoom. Learn how to navigate job descriptions, emphasise desirable skills, and leave a positive impression even after a rejection. This conversation was adapted from a 'Meet the Interviewers' panel at the second edition of the EACR's Early Career Researchers Conference, a much loved virtual conference tailored for early career scientists seeking expert guidance to thrive in all aspects of their research careers. Access transcripts for all our episodes at magazine.eacr.org/podcast. | 31m 47s | ||||||
| 4/12/24 | Research focus: the role of TRAIL in premetastatic niche formation in breast cancer | When studying TRAIL expression in the tumour stroma, Dr Massimiliano Mazzone and Dr Carla Riera-Domingo made a surprising discovery with great therapeutic potential: this immunoregulator acts as a gatekeeper of the vasculature at the pre-metastatic niche. Listen to this episode to find out what implications this has for the formation of the premetastatic niche and the therapeutic value this novel finding holds. You can also read the full episode transcript here: magazine.eacr.org/the-role-of-trail-in-premetastatic-niche-formation-in-breast-cancer-episode-11-of-the-cancer-researcher-podcast This study has been published in Science Advances 9 (12), eadd5028. DOI: 10.1126/sciadv.add5028 and was included in the EACR's Highlights in Cancer Research. | 21m 36s | ||||||
| 2/29/24 | How to Break the Glass Ceiling for Women in Cancer Research | In this episode we continue our exploration of gender diversity in cancer research with Johanna Joyce, Marisol Soengas, and Mireia Crispin Ortuzar. Drawing from the challenges discussed in the previous episode, they discuss practical measures to break the glass ceiling for women in cancer research. They share insights into the importance of supportive networks, mentorship, and the involvement of both men and women in addressing gender disparities. Join us on this journey through statistics, personal experiences, and practical solutions, as we remain dedicated to breaking barriers and promoting equity in cancer research. Access transcripts for all our episodes at magazine.eacr.org/podcast. | 30m 14s | ||||||
| 2/2/24 | Is there a glass ceiling for women in cancer research? | In this episode, we engage in a dynamic discussion on gender diversity in cancer research with guests Johanna Joyce, Marisol Soengas, and Mireia Crispin Ortuzar. Exploring challenges faced by women in science, they address the leaky pipeline, postdoc instability, and the importance of fostering inclusive work environments. Our guests share valuable insights into the need for tailored diversity strategies, supportive networks, and representation at higher career levels in tackling gender disparities. Join us as we navigate through statistics, personal experiences, and practical solutions, working to break barriers and promote equality in cancer research. Access transcripts for all our episodes at magazine.eacr.org/podcast. | 29m 42s | ||||||
| 11/27/23 | Freeing Scientists to Explore: The Role of Curiosity in Cancer Research | Tune in for a journey through the unexpected. In this episode we unravel the magic of curiosity-driven research in revolutionising cancer breakthroughs. Join us with our guests Prof. Ruth Palmer (Sweden), Professor Daniel Peeper (Netherlands) and Professor Iwona Lugowska (Poland) as we explore captivating stories, from DNA sequencing to unexpected discoveries in tyrosine phosphorylation. Discover why nurturing curiosity is crucial and how it shapes the future of cancer research and treatment. Note: Iwona joined us from a windy outside location, so we apologise for the variations in sound quality! Access transcripts for all our episodes at magazine.eacr.org/podcast. | 28m 13s | ||||||
Showing 25 of 32
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
10 placements across 10 markets.
Chart Positions
10 placements across 10 markets.









